SOLIMED TRADING & CONSULTING financials
A multi-period view of the public annual-account figures reported for SOLIMED TRADING & CONSULTING, with comparable measures and links to available source documents.
Company overviewRegistry number
0899162680
Fiscal coverage
2024–2025
Public sources
cbso_bulk
Data updated
Jul 27, 2026
Financial evidence
Latest movements for SOLIMED TRADING & CONSULTING
2025 versus 2024
- Operating line
- €82,579
- EBITDA
- €77,460
- Total assets
- €436,103
- Equity
- €353,710
+61.3%
+70.1%
+16.4%
+3.7%
EBITDA margin +93.8% · Equity ratio +81.1%
Multi-year filings
Source: NBB/CBSOFiled annual accounts by fiscal year
Public regulator-filed figures across 2 years.
Fiscal year | Gross margin | EBITDA | Total assets | Equity | Filing |
|---|---|---|---|---|---|
| 202530 Sept 2025 | €82,579 | €77,460 | €436,103 | €353,710 | - |
| 202430 Sept 2024 | €51,198 | €45,546 | €374,714 | €341,029 | - |
Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.